Xuewei Zhang

Dr. Xuewei Zhang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Brain Research Bulletin
Verified
Journal Article
Closed access
GXGelei Xiao
Gelei Xiao
QCQianwei Chen
Qianwei Chen
XZXuewei Zhang
Xuewei Zhang

12 July 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
BDBinrong Ding
Binrong Ding
XZXuewei Zhang
Xuewei Zhang
ZWZhengqing Wan
Zhengqing Wan
FTFeng Tian
Feng Tian
JLJie Ling
Jie Ling
XPXiaoqing Peng
Xiaoqing Peng
Noninvasive diagnosis of Alzheimer’s disease (AD) is important for patients. Significant differences in the methylation of mitochondrial DNA (mtDNA) were found in AD brain tissue. Cell-free DNA (cfDNA) is a noninvasive and economical diagnostic tool. We aimed to characterize mtDNA methylation alterations in the plasma cfDNA of 31 AD patients and 26 age- and sex-matched cognitively normal control subjects. We found that the mtDNA methylation patterns differed between AD patients and control subjects. The mtDNA was predominantly hypomethylated in the plasma cfDNA of AD patients. The hypomethylation sites or regions were mainly located in mt-rRNA, mt-tRNA, and D-Loop regions. The hypomethylation of the D-Loop region in plasma cfDNA of AD patients was consistent with that in previous studies. This study presents evidence that hypomethylation in the non-protein coding region of mtDNA may contribute to the pathogenesis of AD and potential application for the diagnosis of AD.

6 October 2022 in Cancer Epidemiology
Verified
Journal Article
Closed access
ZZZixuan Zhang
Zixuan Zhang
XZXuewei Zhang
Xuewei Zhang
YGYinyan Gao
Yinyan Gao
YCYancong Chen
Yancong Chen
LQLang Qin
Lang Qin
Xinyin WuXinyin Wu
Xinyin Wu

18 June 2025 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
BDBinrong Ding
Binrong Ding
YWYiqun Wang
Yiqun Wang
JLJunfeng Li
Junfeng Li
XZXuewei Zhang
Xuewei Zhang
ZWZhengqing Wan
Zhengqing Wan
HWHao Wang
Hao Wang
Background: Ischemic stroke (IS) is a major cause of mortality and disability, with atherosclerosis (AS) as a primary risk factor. DNA methylation plays a critical role in AS development, but its regulatory mechanisms remain unclear. This study aims to investigate the epigenetic regulatory mechanisms linking AS and IS by integrating DNA methylation and transcriptome data from public databases.Methods: This study integrated DNA methylation (GSE46394) and transcriptome data (GSE111782 and GSE162955) from public databases to investigate the molecular mechanisms linking AS and IS. Differentially methylated CpG positions (DMPs) and differentially expressed genes (DEGs) were identified (p < 0.05). Subsequent gene annotation and enrichment analyses were performed to uncover potential molecular mechanisms underlying the relationship between AS and IS.Results: A total of 5,396 consistent DMPs were identified in aortic and carotid atherosclerotic lesions, with enriched pathways such as MAPK signaling and Hippo signaling. Transcriptome analysis revealed 1,147 DEGs in AS plaques and 1,321 DEGs in IS brain tissues, enriched in pathways including neuroactive ligand-receptor interactions, calcium signaling, and vascular smooth muscle contraction. Overlapping analyses identified shared processes like actin filament polymerization, cell migration, and MAPK cascade regulation, as well as pathways such as adrenergic signaling, and apelin signaling.Conclusion: This study highlights the pivotal role of epigenetic regulation in AS and IS, uncovering key pathways and molecular processes involved in their progression. Future studies should validate these findings in larger cohorts and integrate multi-omics approaches for a comprehensive understanding.

24 May 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
ZZZixuan Zhang
Zixuan Zhang
YGYinyan Gao
Yinyan Gao
SLShaohui Liu
Shaohui Liu
BDBinrong Ding
Binrong Ding
XZXuewei Zhang
Xuewei Zhang
IWIrene X. Y. Wu
Irene X. Y. Wu
Background: Low-dose computed tomography (LDCT) has been promoted as a promising screening strategy for early detection of lung cancer. China released the latest lung cancer screening guideline in 2021. The compliance of the individuals who received LDCT for lung cancer screening with the guideline is unknown yet. It is necessary to summarize the distribution of guideline-defined lung cancer–related risk factors in the Chinese population so as to inform the selection of target population for the future lung cancer screening.Methods: A single-center, cross-sectional study design was adopted. All participants were individuals who underwent LDCT at a tertiary teaching hospital in Hunan, China, between 1 January and 31 December 2021. LDCT results were derived along with guideline-based characteristics for descriptive analysis.Results: A total of 5,486 participants were included. Over one-quarter (1,426, 26.0%) of the participants who received screening did not meet the guideline-defined high-risk population, even among non-smokers (36.4%). Most of the participants (4,622, 84.3%) were found to have lung nodules, while no clinical intervention was required basically. The detection rate of positive nodules varied from 46.8% to 71.2% when using different cut-off values for positive nodules. Among non-smoking women, ground glass opacity appeared to be more significantly common compared with non-smoking men (26.7% vs. 21.8%).Conclusion: Over one-quarter of individuals who received LDCT screening did not meet the guideline-defined high-risk populations. Appropriate cut-off values for positive nodules need to be continuously explored. More precise and localized criteria for high-risk individuals are needed, especially for non-smoking women.

6 August 2023 in Sleep Medicine
Verified
Journal Article
Closed access
YXYaqin Xiang
Yaqin Xiang
XZXiaoxia Zhou
Xiaoxia Zhou
XHXiuRong Huang
XiuRong Huang
XZXun Zhou
Xun Zhou
QZQian Zeng
Qian Zeng
JGJifeng Guo
Jifeng Guo